Sister chromatid exchanges, which may reflect chromosome repair in response to certain types of DNA damage, provide a means of investigating the increased chromosome fragility characteristic of Fanconi's anemia. By a recently developed technique using 33258 Hoechst and 5-bromodeoxyuridine, it was observed that the baseline frequency of sister chromatid exchanges in phytohemagglutinin-stimulated lymphocytes from four males with Fanconi's anemia differed little from that of normal lymphocytes. However, addition of the bifunctional alkylating agent mitomycin C (0.01 or 0.03 ;Ig/ml) to the Fanconi's anemia cells during culture induces less than half of the increase in exchanges found in identically treated normal lymphocytes. This reduced increment in exchanges is accompanied by a partial suppression of mitosis and a marked increase in chromatid breaks and rearrangements. Many of these events occur at sites of incomplete chromatid interchange. The increase in sister chromatid exchanges induced in Fanconi's anemia lymphocytes by the monofunctional alkylating agent ethylmethane sulfonate (0.25 mg/ml) was slightly less than that in normal cells. Lymphocytes from two sets of parents of the patients with Fanconi's anemia exhibited a normal response to alkylating agents, while dermal fibroblasts from two different patients with Fanconi's anemia reacted to mitomycin C with an increase in chromatid breaks, but a nearly normal increment of sister chromatid exchanges. The results suggest that chromosomal breaks and rearrangements in Fanconi's anemia lymphocytes may result from a defect in a form of repair of DNA damage. Fanconi's anemia is a hereditary disease characterized by pancytopenia, congenital malformations, and patches of increased skin pigmentation (1). Chromosomes from affected individuals exhibit structural lability (2, 3), and there is a strong predisposition for the development of neoplasia (4, 5). Because of the high frequency of chromosomal abnormalities, predominantly breaks, it has been suggested that an error in DNA repair exists in Fanconi's anemia (5).
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Bifunctional alkylating agents such as mitomycin C (6), as well as y-rays (7) , are unusually effective in inducing breaks in chromosomes of peripheral lymphocytes from individuals with Fanconi's anemia. Similarly, mitomycin C has been reported to be highly lethal to fibroblasts cultured from patients with Fanconi's anemia (8) . Monofunctional alkylating agents exhibit less selective toxicity to Fanconi's anemia cells than do their bifunctional counterparts (6, 8) . One recent study has suggested that Fanconi's anemia fibroblasts may also have a reduced ability to excise thymine dimers (9) .
The observation that alkylating agents are able to induce large numbers of sister chromatid exchanges in chromosomes from normal cells (10-12) provides a new approach for investigating Fanconi's anemia. Since sister chromatid exchanges involve the interchange of DNA duplexes between chromatids followed by ligation, they may constitute Abbreviation: EMS, ethylmethane sulfonate. a repair response to chromosome damage. Such an analysis is facilitated by the recent development of fluorescent (13) (14) (15) and related techniques (16) (17) (18) which have largely supplanted autoradiography (19) for the detection of sister chromatid exchanges. In the present report, fluorescence microscopy is used to study sister chromatid exchanges in Fanconi's anemia cells and determine the influence of alkylating agents on the frequency of these exchanges.
MATERIALS AND METHODS
Sister chromatid exchanges in human lymphocyte chromosomes were detected by fluorescence microscopy after staining with the dye 33258 Hoechst (11, 13, (19) (20) (21) (13, 18, 20) . In agreement with a previous report (23) Fig. 3 ). The increment in sister chromatid exchanges induced in Fanconi's anemia lymphocytes is 0.8 that of the normal cells, while the number of chromatid breaks and other aberrations differs little from that in the untreated cells. Thus Fanconi's anemia cells are able to withstand the effects of EMS better than those of mitomycin C.
Three of the individuals with Fanconi's anemia in this study were receiving androgen therapy, and all four were receiving small doses of prednisone. Since administration of the androgenic drug oxymethalone to a patient with Fanconi's anemia previously treated with prednisone was associated with a reduced incidence of chromosome aberrations (25) , lymphocytes from individuals receiving androgens or prednisone for conditions other than Fanconi's anemia were examined. The response of these lymphocytes to EMS or mitomycin C, as measured by the induction of sister chromatid exchanges or chromatid breaks, did not differ from normal. Lymphocytes from parents of two of the patients with Fanconi's anemia were examined. The reaction to alkylating agents of lymphocytes from these individuals was also normal (Table 1) .
DISCUSSION
The reduced ability of cells from patients with Fanconi's anemia to form additional sister chromatid exchanges after exposure to alkylating agents suggests that a defect related to chromosome repair exists in these cells. The convenience and sensitivity of the present cytological technique for detecting DNA damage and repair is somewhat offset by the bias introduced when observing cells at metaphase of the second cycle after addition of BrdUrd to cultures. Selection effects might be circumvented by the utilization of biochemical methods for detecting DNA interchange in material isolated from interphase cells.
Although the DNA repair systems in human cells have not yet been fully delineated, there is evidence that mechanisms analogous to those present in bacteria (26, 27) may exist. Interest in incisional repair, related to the uvr system of bacteria, has been stimulated by observations that most xeroderma pigmentosum cells are defective in an early step involving the excision of thymine dimers from DNA (28, 29) . An alternate repair system, related to recombination, also exists in bacteria (30) . Certain cells (recA) defective in this system are deficient in undergoing genetic recombination and are especially sensitive to killing by a variety of agents (31) , while possession of this function is necessary for bacteria to respond to DNA crosslinking with an interchange between sister DNA molecules (32) . The increase in sister chromatid exchanges in human cells treated with alkylating agents bears at least a superficial resemblance to recombinational repair (20) . It is tempting to speculate that this process may somehow be defective in Fanconi's anemia lymphocytes. Whatever its basis, the reduced inducibility of sister chromatid exchanges observed in Fanconi's anemia lymphocytes may ultimately be of diagnostic use.
The possibility that the paucity of induced sister chromatid exchanges may be related to the increase in chromatid breaks in Fanconi's anemia lymphocytes is supported by the observation that many of these breaks occur at sites of incomplete sister chromatid exchange. The fraction of breaks occurring at such sites may relate to the frequency with which repair of mitomycin C damage is accompanied by the interchange of DNA between sister chromatids. Compared with mitomycin C, EMS induces a relatively greater number of sister chromatid exchanges with a lesser increase in chromatid breaks in Fanconi's anemia lymphocytes. This suggests that a step needed for the repair of damage induced by bifunctional, but not monofunctional, alkylating agents may be deficient in this disease. Whereas, more than one type of reaction product might be expected with each agent, the predominant consequences should differ. Thus, monofunctional agents characteristically react with guanine residues, labilizing the DNA to depurination, which in turn is often followed by a polynucleotide chain break (33, 34) . A single such series of events occurring after a bifunctional alkylation, e.g., with mitomycin C (34, 35) , would still leave a fragment attached to a second polynucleotide chain, to be removed. In analogy with the heterogeneity of the lesion in xeroderma pigmentosum (36) , it is possible that errors in any of a group of steps might produce the chromosome aberrations observed in Fanconi's anemia. Examination of the effects of other agents capable of inducing sister chromatid exchanges should assist characterization of DNA repair processes in Fanconi's anemia.
The parents of patients with Fanconi's anemia exhibit a normal sister chromatid exchange response after mitomycin C or EMS treatment. This is consistent with an autosomal recessive inheritance mode which has previously been postu-Proc. Nat. Acad. Sci. USA 72 (1975) lated (1) for this disease. Fanconi's anemia occurs in both sexes, although in one large study (1) , females accounted for only one-third of the cases observed. It is thus possible that there is a sex-dependent effect on the expression of this disease, and the existence of several forms of the disease, with a heterogeneous genetic basis, cannot be excluded.
Abnormal chromosome morphology in Fanconi's anemia has been observed in peripheral lymphocytes (6, 7) , bone marrow cells (37) , and cultured fibroblasts (3). The principal observation reported here is that phytohemagglutinin-stimulated lymphocytes from patients with the clinical diagnosis of Fanconi's anemia exhibit a markedly deficient ability to respond to mitomycin C with an increase in sister chromatid exchanges. They exhibit an abnormally high number of chromatid breaks, many occurring at sites of incomplete sister chromatid exchange. The nearly normal increment of exchanges after mitomycin C treatment of the lines of dermal fibroblasts examined suggests that different tissues may be unequally affected in Fanconi's anemia. Examination of fibroblasts and lymphocytes from the same individuals would help to test this hypothesis. Alternatively, the results may reflect differences between details of the culture conditions,. which in turn exert unequal selective pressures on lymphocytes and fibroblasts. While the results of the present study could account for the characteristic chromosome changes in Fanconi's anemia lymphocytes, it is not yet clear how they relate to clinical features of the disease.
The defective sister chromatid exchange response in Fanconi's anemia lymphocytes contrasts sharply with-the marked increase in exchanges observed in Bloom's syndrome (23) in the absence of alkylating agents. Both diseases involve chromosome structural abnormalities and a predisposition for the development of neoplasia. In a third disease, ataxia telangiectasia, which is also characterized by these same two features, the frequency of sister chromatid exchange is normal (23) , but specific rearrangements involving chromosome no. 14 have been observed (38) . Cytological data differentiating the diseases described should stimulate a search for associated biochemical changes in these and related conditions.
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